arrow
A

Angela Choi

ica hn school of medicine at mount sinai
H指数:29
被引数:4,909

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

一项针对mRNA-1010季节性流感疫苗在成人中的III期随机安全性及免疫原性试验

VACCINE
IF3.5
2025-03-014
PRE
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus
2024-12-180
PRE
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2
2023-09-137
PRE
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

接种疫苗的人和小鼠对SARS-CoV-2变异的不同敏感性

2022-08-0110
OAAI
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
2022-07-0723
OAAI
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
2021-09-15286
OAAI
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
2021-08-2041
OAAI
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine (vol 60, pg 9467, 2021)
2021-07-192
OAAI
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine**
2021-03-1150
OA
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

大流行性流感病毒疫苗可增强成年和儿科人群的血凝素茎特异性抗体反应

2019-12-0623
OAAI